Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu dopisy
PubMed
35482558
DOI
10.1111/bjh.18219
Knihovny.cz E-zdroje
- Klíčová slova
- allogeneic stem cell transplant, chronic eosinophilic leukaemia, conditioning, hypereosinophilic syndrome, non-relapse mortality,
- MeSH
- lidé MeSH
- nádory * MeSH
- nemoc štěpu proti hostiteli * etiologie MeSH
- příprava pacienta k transplantaci MeSH
- retrospektivní studie MeSH
- transplantace hematopoetických kmenových buněk * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
CHU de Lille Univ Lille INSERM U1286 Infinite Lille France
Clínica Universitaria de Navarra Pamplona Spain
Department of Haematology and Oncology Charles University Hospital Pilsen Czech Republic
Department of Haematology and Stem Cell Transplantation University Hospital Essen Germany
Department of Haematology Nottingham University Hospital Nottingham UK
Department of Haematology Trinity College Dublin St James's Hospital Dublin Ireland
Department of Hematology and Transplantology Medical University of Gdańsk Gdańsk Poland
Department of Hematology Hospital Clínico Universitario Valencia Spain
Department of Stem Cell Transplant Hopital La Miletrie Poitiers France
EBMT Leiden Study Unit Leiden The Netherlands
EBMT Statistical Unit Leiden The Netherlands
Hannover Medical School Hannover Germany
Hôpital Saint Louis APHP Université de Paris Paris France
HUCH Comprehensive Cancer Center Helsinki Finland
Leiden University Hospital Leiden The Netherlands
Maria Skłodowska Curie National Research Institute of Oncology Gliwice Poland
Medizinische Klinik m S Hämatologie Onkologie und Tumorimmunologie Berlin Germany
Paediatric Haematology Oncology Fondazione IRCCS Policlinico San Matteo Pavia Italy
RM Gorbacheva Research Institute Pavlov University St Petersburg Russia
Zobrazit více v PubMed
Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:129-48.
Basara N, Markova J, Schmetzer B, Blau IW, Kiehl MG, Bischoff M, et al. Chronic eosinophilic leukemia: successful treatment with an unrelated bone marrow transplantation. Leuk Lymphoma. 1998;32:189-93.
Halaburda K, Prejzner W, Szatkowski D, Limon J, Hellmann A. Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript. Bone Marrow Transplant. 2006;38:319-20.
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2009;15:1628-33.
Butt NM, Lambert J, Ali S, Beer PA, Cross NCP, Duncombe A, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176:553-72.
Helbig G, Soja A, Bartkowska-Chrobok A, Kyrcz-Krzemień S. Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation. Am J Hematol. 2012;87:643-5.
Morsia E, Reichard K, Pardanani A, Tefferi A, Gangat N. WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): a contemporary series from the Mayo Clinic. Am J Hematol. 2020;95:E172-4.
